I don’t have any issue with the business model and loyalty. I understand it’s application in the gold mining industry. What I want to see is it work for cannabinoids. Especially the ones that are extremely similar in molecular weight and boiling point and tend to coelude.
I think there’s potential in this, but so far, “trust us, it’ll work” is the best anybody can produce. There’s lots of potential customers out there, but we want to see it work, and have the results independently tested. If you can’t show me it doing what it’s supposed to do…don’t have a client set up who can show me this thing doing what it’s supposed to do… and can’t return phone calls, even in a pandemic when you literally have nothing better to do work wise, there might be a problem…
I personally think it seems like a totally valid technology and i’m sure either currently or with more R&D it can hit it’s targets technically speaking. My only issue was with the lease model, because the amount they were charging was so exorbitantly huge that even if this did 100% of the things they claim, it still wouldn’t be worth it.
When sixth wave gets to where they have a functional unit, in a functioning laboratory, somewhere in the continental US, where we can see it work and get some samples to have tested this will be worth talking about. Until then, it’s a bunch of speculation about a supposedly coming soon unproven doodad.
I’ve had the pleasure of speaking at length with the father’s of this invention. Not 6th Wave…but the source. It works far as I have seen with the analytics shared and visual presentation I received. Not in person mind you…but the high bar of entry turned me back the way I came from … the world of reactions … the MIPs are likely legit … and the royalties were idyllic at optimum throughput … the higher the volume the lower the COG and Royalty payments … plus the ability to isolate and seperate each minor individually and with alcohol was attractive … but close to $3/4 mm for the system at cost was very risky in this volatile market